Rockville, Md.—A paper Abt Global coauthored shows that COVID-19 specimen-collection methods other than traditional nasal swabs are accurate in detecting SARS-CoV-2 infections. SARS-CoV-2 is the virus that causes COVID-19 illness. A variety of options for testing is critical because of global supply shortages faced during a public health emergency such as a pandemic.
Abt Global, which collects data on COVID-19 transmission and vaccine effectiveness for the Centers for Disease Control and Prevention (CDC), explored several approaches. The normal protocol, the gold standard for testing for this type of virus, was to use traditional, soft-tipped nasal swabs. Study participants placed them in tubes with liquid and sent them in for analysis. The other methods Abt tested were saliva put in cups and foam-tipped swabs put in empty tubes.
Participants with at least one COVID-19 symptom from three CDC-sponsored studies provided specimens for all three collection methods. The results, which were published in Microbiology Spectrum, showed that saliva and foam-tipped swabs provided the sensitivity and specificity (true positives and true negatives) required. The analysis showed 97 percent positive results for soft-tipped swabs, 99 percent for saliva, and 89 percent for foam-tipped swabs.
“This paper shows there are alternatives to the most commonly used swab test for COVID-19 testing,“ says Jazmin Duque, the Abt lead for the Coronavirus Household Evaluation and Respiratory Testing (C-HEaRT) study. “This allows us to address supply shortages in the setting of a public health emergency.”
The saliva option is particularly attractive for children. “They have fun drooling into a funnel,” Duque says. “It’s a more appealing option than sticking a swab up their noses.”
The specimens came from 1,900 participants in three studies: C-HEaRT, the Abt-led Research on the Epidemiology of SARS-CoV-2 in Essential Response personnel, and the University of Arizona’s Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance study. They produced more than 4,000 specimens. The paper’s merger of data from three studies shows the value of carrying out different studies using similar protocols.
Read more on the study findings here.
About Abt Global
Abt Global is a global consulting and research firm that combines data and bold thinking to improve the quality of people's lives. We partner with clients and communities to advance equity and innovation—from creating scalable digital solutions and combatting infectious disease, to mitigating climate change and evaluating programs for measurable social impact. https://www.abtglobal.com
Contact:
Stan Crock
stan_crock@abtassoc.com
(301) 347-5402
Read Our Latest News
Abt to Evaluate Sickle Cell Disease Treatment; Improve Quality in Nursing Homes, Post-Acute Care Settings
Abt Global is helping CMS determine whether a new program increases access to cell and gene therapy treatment while reducing healthcare costs.
Abt to Manage Australia’s Main Development Program for Fiji
The Australian Government recently awarded Abt Global a contract to manage a $90 million umbrella program covering half of Australia’s development assistance to Fiji.
Abt Leads Decision Support for FCDO Land Governance Programme
Abt Global Britain has been appointed to lead the Decision Support Unit of the Land Facility, funded by the UK’s Foreign and Commonwealth Development Office.
Public Warning: Recruitment Phishing Scam Impersonating Abt Global
Abt Global has become aware of a phishing scheme targeting individuals with fraudulent interview requests and job offers. Abt’s secure IT systems and private applicant information have not been compromised; scammers are impersonating Abt employees, using the company name and branding to mislead and engage potential job seekers in fake recruitment processes. Scammers might reference real job openings or describe fake opportunities that generally match individuals’ professional backgrounds, with the goal of establishing communication and eventually obtaining private financial information to defraud people. The Federal Bureau of Investigation and Federal Trade Commission warn that employment scams such as this are a growing cyber threat. Abt urges anyone who is contacted about employment opportunities to exercise caution and know that: All communication from Abt Global will be from an Abt employee using the @abtglobal.com email domain (e.g., recruiting@abtglobal.com). We do not use third-party recruiters. Abt Global recruiters will only schedule interviews for candidates who have applied for a position through our secure portal. You may view your application status through the applicant portal on Abt Global Careers. No corporate or IT systems at Abt are affected by this scam. The scammers are using Abt’s logo and employee names to impersonate the company. You can directly contact us at recruiting@abtglobal.com with any questions or concerns. Abt is committed to ensuring the safety and security of our community. We caution individuals to be vigilant in protecting personal data and vetting communication with new contacts from any company. Do not respond or provide any personal information if contacted by someone claiming to represent a company to which you did not submit a job application or profile. This scam can be perpetrated against any business and individuals who recognize and trust its name. For information on Abt recruitment practices and policies, please visit our careers page or email recruiting@abtglobal.com. To report a scam, visit: https://reportfraud.ftc.gov/.